Daily News

NIH would receive a $2 billion increase . . .

House Spending Deal Gives FDA Hike; Broaches Compounding, LDTs, Staff Cuts, Budget Gimmicks

May 01, 2017
Congressional leaders are pushing a tentative bipartisan fiscal 2017 funding agreement that would give FDA $39 million more than its fiscal 2016 enacted level. The agreement instructs FDA to work with Congress on a variety of issues, including compounding, regulation of laboratory-developed tests and agency staffing levels, and blocks the administration from using unrealistic user fee requests as a means of artificially boosting the agency's budget. The spending deal also provides a $2 billion increase for the National Institutes of...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.